M&A Deal Summary |
|
---|---|
Date | 2021-09-09 |
Target | Ketamine Wellness Centers |
Sector | Consumer Services |
Buyer(s) | Delic |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Delic was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic is the ?first psychedelic umbrella platform and is currently a trusted source for those interested in ?psychedelic culture, psychedelic clinics, and more. ?
DEAL STATS | # |
---|---|
Overall | 3 of 3 |
Sector (Consumer Services) | 1 of 1 |
Type (Add-on Acquisition) | 3 of 3 |
State (Arizona) | 2 of 2 |
Country (United States) | 2 of 2 |
Year (2021) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-05-27 |
Complex Biotech Discovery Ventures
Vancouver, British Columbia, Canada Complex Biotech Discovery Ventures is a federally authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. CBDV supports the psychedelic industry with high precision chemical analytics and metabolomic identification. It is one of a handful of licensed research psilocybin labs in Canada and has an aggressive plan to build out a suite of novel compounds and delivery methods for the industry. The company is also a leading cannabis analytical and research company boasting clients that include some of the largest brands in the world. CBDV has applied for its dealer's license and intends to eventually commercialize its psilocybin research and associated intellectual property (IP). Complex Biotech Discovery Ventures was formed in 2018 and is based in Vancouver, British Columbia. |
Buy | $7M |